Advertisement

The Indian Journal of Pediatrics

, Volume 85, Issue 11, pp 963–967 | Cite as

Comparison of Four Days Versus Seven Days Duration of Antibiotic Therapy for Neonatal Pneumonia: A Randomized Controlled Trial

  • N. B. Mathur
  • A. Murugesan
Original Article

Abstract

Objective

To compare the effect of 4 day course (study group) with 7 day course (control group) of antibiotic treatment in neonatal pneumonia, on treatment success rate.

Methods

This randomized controlled trial was conducted in a tertiary teaching hospital. Seventy, term and near-term neonates with pneumonia who had clinical remission by 48 h of antibiotic therapy were included. The neonates were randomized to receive a total of 4 d of antibiotics (Group 1) or 7 d of antibiotics (Group 2). The outcome measure was treatment failure in each group within 3 d of discharge.

Results

The treatment success rate of both the groups was 100%. There was a significant reduction in the duration of hospital stay (p < 0.001), antibiotic usage (p < 0.001), and cost (p < 0.001) in the 4 d group. On follow up till 28 d of enrollment, no infective morbidity was found in either group.

Conclusions

For term and near-term neonates who become clinically asymptomatic within 48 h of antibiotic therapy, 4 d of antibiotic therapy is as effective and safe as 7 d of antibiotic therapy, with significant reduction in hospital stay, antibiotic usage and cost.

Keywords

Duration of antibiotics Effectiveness Neonatal pneumonia Treatment failure 

Notes

Contributions

NBM conceptualized and designed the study, finalized the manuscript and is guarantor of the paper. AM was involved in acquisition of data and drafted the manuscript.

Compliance with Ethical Standards

Conflict of Interest

None.

References

  1. 1.
    Bang AT, Bang RA, Morankar VP, Sontakke PG, Solanki JM. Pneumonia in neonates: can it be managed in the community? Arch Dis Child. 1993;68:550–6.CrossRefGoogle Scholar
  2. 2.
    Duke T. Neonatal pneumonia in developing countries. Arch Dis Child Fetal Neonatal Ed. 2005;90:211–9.CrossRefGoogle Scholar
  3. 3.
    Morrins AM. Antimicrobial stewardship programs: appropriate measures and metrics to study their impact. Curr Treat Options Infect Dis. 2014;6:101–12.CrossRefGoogle Scholar
  4. 4.
    Wise R, Hart T, Cars O, et al. Antimicrobial resistance. Is a major threat to public health. BMJ. 1998;317:609–10.CrossRefGoogle Scholar
  5. 5.
    Remington JS, Klein JO. Bacterial infections of the respiratory tract: pneumonia. In: Remington JS, Klein JO, Wilson CB, Baker CJ, editors. Infectious diseases of the fetus and the newborn infant. 7th ed. New York: Elsevier; 2011. p. 285–92.Google Scholar
  6. 6.
    Engle WD, Jackson GL, Sendelbach D, et al. Neonatal pneumonia: comparison of 4 vs 7 days of antibiotic therapy in term and near term infants. Am J Perinatol. 2000;20:421–6.CrossRefGoogle Scholar
  7. 7.
    Zhong B. How to calculate sample size in randomised controlled trial? J Thorac Dis. 2009;1:51–4.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Hengst JM. The role of C-reactive protein in the evaluation and management of infants with suspected sepsis. Adv Neonatal Care. 2003;3:1–13.CrossRefGoogle Scholar
  9. 9.
    Chiesa C, Panero A, Rossi N, Stegagno M, Giusti MD, Osborn JF. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis. 1998;26:664–72.CrossRefGoogle Scholar
  10. 10.
    Stocker M, Fontana M, El Helou S, Wegscheider K, Berger TM. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology. 2010;97:165–74.CrossRefGoogle Scholar
  11. 11.
    Mathur NB, Garg K, Kumar S. Respiratory distress in neonates with special reference to pneumonia. Indian Pediatr. 2002;39:529–37.PubMedGoogle Scholar
  12. 12.
    Sivanandan S, Soriasham AS, Swarnam K. Choice and duration of antimicrobial therapy for neonatal sepsis and meningitis. Int J Pediatr. 2011;2011: 712150:9.CrossRefGoogle Scholar
  13. 13.
    Cotton CM, Taylor S, Stoll B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotising enterocolitis and death for extremely low birth weight infants. Pediatrics. 2009;123:58–66.CrossRefGoogle Scholar
  14. 14.
    Cotton CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin DK Jr; National Institute for Child Health and Human Development Neonatal Research Network. The association of third generation cephalosporin use and invasive candidiasis in extremely low birth weight infants. Pediatrics. 2006;118:717–22.CrossRefGoogle Scholar
  15. 15.
    Saini SS, Dutta S, Ray P, Narang A. Short course versus 7-day course of intravenous antibiotics for probable neonatal septicaemia: a pilot, open label, randomized control trial. Indian Pediatr. 2011;48:19–24.CrossRefGoogle Scholar
  16. 16.
    Chowdhary G, Dutta S, Narang A. Randomized controlled trial of 7-day vs. 14-day antibiotics for neonatal sepsis. J Trop Pediatr. 2006;52:427–32.CrossRefGoogle Scholar
  17. 17.
    Gathwala G, Sindani A, Singh J, Choudhry O, Chaudhary U. Ten days vs 14 days antibiotic therapy in culture proven neonatal sepsis. J Trop Pediatr. 2010;56:433–5.CrossRefGoogle Scholar
  18. 18.
    Pasha YZ, Ahmadpour-Kacho M, Behmadi R, Jahangir T. 3-day versus 5-day course of intravenous antibiotics for suspected early onset neonatal sepsis: a randomized controlled trial. Iran J Pediatr. 2014;24:673–8.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Mathur NB, Kharod P, Kumar S. Evaluation of duration of antibiotic therapy in neonatal bacterial meningitis: a randomized controlled trial. J Trop Pediatr. 2015;61:119–25.CrossRefGoogle Scholar
  20. 20.
    Meisner M. Update on procalcitonin measurements. Ann Lab Med. 2014;34:263–73.CrossRefGoogle Scholar
  21. 21.
    Monneret G, Labaune JM, Isaac C, Bienvenu F, Putet G, Bienvenu J. Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr. 1997;86:209–12.CrossRefGoogle Scholar
  22. 22.
    Delèvaux I, André M, Colombier M, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis. 2003;62:337–40.CrossRefGoogle Scholar
  23. 23.
    Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. Am J Respir Crit Care Med. 2006;174:84–92.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2018

Authors and Affiliations

  1. 1.Department of NeonatologyMaulana Azad Medical CollegeNew DelhiIndia
  2. 2.Department of PediatricsMaulana Azad Medical CollegeNew DelhiIndia

Personalised recommendations